What's Hot

    Rob Lowe reveals he prayed for Charlie Sheen for years amid sobriety journey | Invesloan.com

    November 20, 2026

    Race to Prove Riemann Hypothesis Just Became a Human-Versus-AI Showdown | Invesloan.com

    November 20, 2026

    Dow, S&P 500 enter correction as Nasdaq suffers worst week since 2020 | Invesloan.com

    November 20, 2026
    Facebook Twitter Instagram
    Finance Pro
    Facebook Twitter Instagram
    invesloan.cominvesloan.com
    Subscribe for Alerts
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    invesloan.cominvesloan.com
    Home » FDA nominee Heidi Overton dedicated to abortion tablet security research timeline | Invesloan.com
    Politics

    FDA nominee Heidi Overton dedicated to abortion tablet security research timeline | Invesloan.com

    November 20, 2026Updated:November 20, 2026
    Share
    Facebook Twitter LinkedIn Pinterest Email

    NEWYou can now listen to Fox News articles!

    FIRST ON FOX: Dr. Heidi Overton, a former nominee for Food and Drug Administration (FDA) commissioner, had committed to establishing a binding timeline and clear parameters for a safety study on the abortion medication mifepristone, the office of Sen. Josh Hawley, R-Mo., told Fox News Digital Friday.

    Hawley, a member of the Senate Health, Education, Labor and Pensions (HELP) Committee, has spent months pressing federal health officials for accountability over the delayed assessment.

    “These are major pro-life wins that help ensure a robust study and the potential reinstatement of critical safeguards on the abortion drug that President Biden stripped away,” Hawley said in a statement to Fox News Digital. 

    “I will expect that the FDA will live up to these promises, and as a member of the HELP Committee, any future FDA commissioner nominee must commit to carrying this through in order to earn my support.”

    TRUMP TO NOMINATE DR HEIDI OVERTON AS NEXT FDA COMMISSIONER

    Side-by-side image of Mifepristone boxes and Sen. Josh Hawley

    Sen. Josh Hawley, R-Mo., who sits on the Senate Health, Education, Labor and Pensions Committee, said he had secured commitments from Dr. Heidi Overton, nominee for Food and Drug Administration commissioner, to establish a binding timeline and data parameters for a safety study on the abortion medication mifepristone. (Evelyn Hockstein/Reuters; Tom Williams-Pool/Getty Images)

    The White House pulled Heidi Overton’s nomination one day before a Senate committee vote. President Donald Trump hailed Overton as a “ROCKSTAR” in August when he picked the physician and White House advisor to succeed Marty Makary, who resigned in May.

    According to Hawley’s office, the Trump administration had pledged to finalize a comprehensive mifepristone safety study by March 2027, with the FDA committing to enact regulatory changes supported by the findings no later than September 2027.

    Updated safety protocols would have applied to both brand-name mifepristone and its generic equivalents.

    FEDERAL APPEALS COURT BLOCKS MAILING OF ABORTION PILLS IN RULING WITH NATIONWIDE EFFECT

    Josh Hawley

    Sen. Josh Hawley, R-Mo., arrives for a Senate Health, Education, Labor, and Pensions Committee confirmation hearing in Washington, D.C., Sept. 24, 2026. (Daniel Heuer/Bloomberg via Getty Images)

    Hawley’s office noted that the potential study will analyze Medicaid and commercially available data spanning periods before and after the Biden administration lifted restrictions.

    Federal oversight of the medication has drawn sustained scrutiny since 2023, when the Biden administration eliminated requirements mandating in-person doctor visits and in-person dispensing.

    HAWLEY URGES DOJ PROBE INTO ABORTION PILL MAKER OVER SAFETY CONCERNS

    The FDA’s review has faced repeated postponements despite earlier pledges by officials to release a study in 2025 amid concerns from critics that the agency was excluding critical data.

    “FDA has explained its intention to quickly complete its ongoing review using appropriate data and qualified experts, follow the evidence, and make the scientific basis and results public to the greatest extent permitted by law,” Overton wrote in her Senate committee confirmation questionnaire prior to her nomination being pulled.

    WHITE HOUSE PULLS TRUMP’S FDA PICK HEIDI OVERTON ON EVE OF SENATE PANEL VOTE

    FILE - The Food and Drug Administration campus in Silver Spring, Md., is seen, Oct. 14, 2015. (AP Photo/Andrew Harnik, File)

    The Food and Drug Administration campus in Silver Spring, Md., Oct. 14, 2015. (AP Photo/Andrew Harnik, File)

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    “If confirmed, I would support completing that work as expeditiously as practicable while preserving the integrity of the scientific review,” she added.

    In March, Hawley urged fellow Republicans to back his legislation to ban mifepristone.

    “The evidence is now clear,” he said at the time. “Mifepristone is almost always fatal to the unborn child, but it is also significantly dangerous for women. The drug companies that make this drug know this but continue to profit from the drug’s nearly unregulated distribution, largely insulated from liability. Congress can no longer ignore these dangers.” 

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Keep Reading

    Rob Lowe reveals he prayed for Charlie Sheen for years amid sobriety journey | Invesloan.com

    Bernie Moreno leads Senate tribute to Fiona the hippo after her loss of life | Invesloan.com

    Cardinals might begin their fourth QB in 4 weeks as Carson Beck has harm after first profession begin | Invesloan.com

    Trump says he would nonetheless launch struggle in opposition to Iran after Vance midterm blame | Invesloan.com

    James Carville calls out Pramila Jayapal over Hakeem Jeffries comment | Invesloan.com

    Melania Trump helps negotiate Ukraine ceasefire, evacuation | Invesloan.com

    Mamdani disbanded NYPD Special Response Group that after arrested him | Invesloan.com

    Ella Langley celebrates historic CMA Awards night time with viral Instagram put up nearing 900,000 likes | Invesloan.com

    Sen. Jim Risch warns of horrific pattern of Christians killed in Ethiopia | Invesloan.com

    LATEST NEWS

    Rob Lowe reveals he prayed for Charlie Sheen for years amid sobriety journey | Invesloan.com

    November 20, 2026

    Race to Prove Riemann Hypothesis Just Became a Human-Versus-AI Showdown | Invesloan.com

    November 20, 2026

    Dow, S&P 500 enter correction as Nasdaq suffers worst week since 2020 | Invesloan.com

    November 20, 2026

    Bernie Moreno leads Senate tribute to Fiona the hippo after her loss of life | Invesloan.com

    November 20, 2026
    POPULAR

    China’s first passenger jet completes maiden commercial flight

    May 28, 2023

    Numbers taking US accountancy exams drop to lowest level in 17 years

    May 29, 2023

    Toyota chair faces removal vote over governance issues

    May 29, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!
    Facebook Twitter Pinterest WhatsApp Instagram
    © 2007-2023 Invesloan.com All Rights Reserved.
    • Privacy
    • Terms
    • Press Release
    • Advertise
    • Contact

    Type above and press Enter to search. Press Esc to cancel.

    invesloan.com
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}